Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03241082

Ultrasound Assessment of BC in the NICU

The overall objective of the proposal is to evaluate the ability of ultrasound to predict and routinely (weekly) monitor changes in the body composition of healthy preterm infants in the neonatal intensive care unit (NICU) in response to nutritional intake. The investigators hypothesize that ultrasound is an accurate method to routinely monitor the quality of weight gain and assess the adequacy of nutritional provision for premature infants in the neonatal intensive care unit.

The investigators will address the hypothesis in the following Specific Aims:

Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat free mass in healthy, premature infants. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP). Stable isotope dilution techniques will be used in a subset of our population as a secondary source of validation.

Specific Aim 2: Determine whether ultrasound measurements can detect clinically relevant (weekly) changes in body composition in healthy premature infants. Ultrasound will be used to obtain serial (weekly) measurements of muscle and adipose tissue thickness (triceps, abdomen, quadriceps) until discharge in healthy, premature infants.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

25 week–34 week

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Minnesota Masonic Children's Hospital

Minneapolis, Minnesota, 55455, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy, premature infants 25-34+6 weeks gestational age at birth
  • Admitted to the University of Minnesota Masonic Children's Hospital NICU
  • Stable on room air or can be removed from respiratory support for 5 minutes
  • Written or verbal (telephone) informed consent can be secured from a parent within 1 week of admission to the NICU

Exclusion criteria

-Require medical support preventing ADP measurements

Treatment and study plan

Ultrasound

Device

validation of portable ultrasound to measure body composition

Primary outcomes

  1. Whole-body measurements of body composition

    Time frame: Up to 6 weeks

    Measurement of whole body fat mass and fat-free mass via air displacement plethysmography and stable isotope dilution.

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Official study title

Use of Bedside Ultrasound to Assess Neonatal Body Composition in the Neonatal Intensive Care Unit

Important dates

Study start
2017
Primary completion
2022
Study completion
2027
First posted
Aug 7, 2017
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting

Cycled Phototherapy

NCT03927833

Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications

Birmingham, Alabama, United States

View Trial Details